Evidence map›Paper›PMID 35620911›Full record

ArticleTissue engineering. Part A2022

Pharmaceutical Agents for Contractile-Metabolic Dysfunction After Volumetric Muscle Loss.

Jennifer McFaline-Figueroa, Albino G Schifino, Anna S Nichenko, Magen N Lord, Edward T Hunda, Elizabeth A Winders, Emily E Noble, Sarah M Greising, Jarrod A Call

Open access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part A, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Low intensity, high frequency vibration training to improve musculoskeletal function in a mouse model of volumetric muscle loss.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2025
    Article
  9. Article
  10. Article
  11. Tibial bone strength is negatively affected by volumetric muscle loss injury to the adjacent muscle in male mice.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jennifer McFaline-FigueroaDepartment of Physiology & Pharmacology, University of Georgia, Athens, Georgia, USA.ORCID 0000-0001-8229-6121
Albino G SchifinoDepartment of Physiology & Pharmacology, University of Georgia, Athens, Georgia, USA.
Anna S NichenkoDepartment of Physiology & Pharmacology, University of Georgia, Athens, Georgia, USA.
Magen N LordDepartment of Nutritional Sciences, University of Georgia, Athens, Georgia, USA.
Edward T HundaRegenerative Bioscience Center, University of Georgia, Athens, Georgia, USA.
Elizabeth A WindersRegenerative Bioscience Center, University of Georgia, Athens, Georgia, USA.
Emily E NobleDepartment of Nutritional Sciences, University of Georgia, Athens, Georgia, USA.
Sarah M GreisingSchool of Kinesiology, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0001-9285-4908
Jarrod A CallDepartment of Physiology & Pharmacology, University of Georgia, Athens, Georgia, USA.
University of Georgia · USUniversity of Minnesota · US

Funding

Melanin-concentrating hormone and the neural regulation of feedingK01DK118000 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI NOBLE, EMILY ELIZABETH · 2019 to 2023
$769k
NIDDK NIH HHS K01 DK118000
6 · The paper itself

Abstract

Volumetric muscle loss (VML) injuries represent a majority of military service member casualties and are common in civilian populations following blunt and/or penetrating traumas. Characterized as a skeletal muscle injury with permanent functional impairments, there is currently no standard for rehabilitation, leading to lifelong disability. Toward developing rehabilitative strategies, previous research demonstrates that the remaining muscle after a VML injury lacks similar levels of plasticity or adaptability as healthy, uninjured skeletal muscle. This may be due, in part, to impaired innervation and vascularization of the remaining muscle, as well as disrupted molecular signaling cascades commonly associated with muscle adaptation. The primary objective of this study was to assess the ability of four pharmacological agents with a strong record of modulating muscle contractile and metabolic function to improve functional deficits in a murine model of VML injury. Male C57BL/6 mice underwent a 15% multimuscle VML injury of the posterior hindlimb and were randomized into drug treatment groups (formoterol [FOR], 5-aminoimidazole-4-carboxamide riboside [AICAR], pioglitazone [PIO], or sildenafil [SIL]) or untreated VML group. At the end of 60 days, the injury model was first validated by comparison to age-matched injury-naive mice. Untreated VML mice had 22% less gastrocnemius muscle mass, 36% less peak-isometric torque, and 27% less maximal mitochondrial oxygen consumption rate compared to uninjured mice (

Indexed as

Muscular DiseasesRegenerationAnimalsFormoterol FumarateMaleMiceMice, Inbred C57BLMuscle, SkeletalPharmaceutical PreparationsQuality of LifeFormoterol FumaratePharmaceutical Preparationsmitochondria respirationmuscle strengthregenerative rehabilitationtraumatic injury

Identifiers

PMID35620911
PMCPMC9634984
OpenAlexW4281668648

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.